According to Ojing Medical's announcement, the cumulative deviation value of the closing price drop of the company's shares exceeded 30% for 3 consecutive trading days, which is an abnormal fluctuation in stock trading. After self-inspection and verification with Eric Gang Hu, the largest shareholder, there were no important matters that should have been disclosed but not disclosed, and the directors and supervisors did not trade the company's shares during the change period. The company needs to review early financial data, or involves correction of early accounting errors, and is unable to disclose the report for the third quarter of 2026 as scheduled; the company has been investigated by the China Securities Regulatory Commission. If a major illegal forced delisting situation is encountered, the stock will be subject to major illegal forced delisting. Investors are kindly requested to pay attention to investment risks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.